Marine Microalgal Products with Activities against Age-Related Cardiovascular Diseases.
Nova YurikaEleonora MontuoriChiara LauritanoPublished in: Marine drugs (2024)
Heart disease is one of the leading causes of death worldwide, and it is estimated that 17.9 million people die of it each year. The risk factors for cardiovascular diseases are attributable to an unhealthy and sedentary lifestyle, poor nutrition, stress, genetic predisposition, diabetes, obesity, and aging. Marine microalgae have been the subject of numerous studies for their potential activity against several human diseases. They produce a plethora of primary and secondary metabolites such as essential nutrients, vitamins, pigments, and omega-3 fatty acid. Many of these molecules have antioxidant properties and have been shown to play a role in the prevention of heart diseases. The aim of this review is to summarize recent studies on the discovery of marine microalgal compounds and bioactivities for cardiovascular diseases, including in vitro and in vivo studies, showing and discussing recent discoveries and trends. The most promising results were found for microalgal polysaccharides, peptides and carotenoids. In conclusion, the overall data summarized here show that microalgae-based supplementation has the potential to improve age-related cardiovascular diseases and we expect more clinical studies in the future.
Keyphrases
- cardiovascular disease
- type diabetes
- physical activity
- case control
- fatty acid
- metabolic syndrome
- cardiovascular risk factors
- cardiovascular events
- endothelial cells
- weight loss
- small molecule
- insulin resistance
- heart failure
- ms ms
- pulmonary hypertension
- electronic health record
- oxidative stress
- heavy metals
- adipose tissue
- coronary artery disease
- human health
- big data
- body mass index
- dna methylation
- anti inflammatory
- induced pluripotent stem cells
- current status
- single cell
- deep learning
- amino acid